376 related articles for article (PubMed ID: 30066201)
21. Comparison of patterns of care in lung cancer in three area health services in New South Wales, Australia.
Vinod SK; Hui AC; Esmaili N; Hensley MJ; Barton MB
Intern Med J; 2004 Dec; 34(12):677-83. PubMed ID: 15610212
[TBL] [Abstract][Full Text] [Related]
22. Variations in hospital inpatient palliative care service use: a retrospective cohort study.
Assareh H; Stubbs JM; Trinh LTT; Greenaway S; Agar M; Achat HM
BMJ Support Palliat Care; 2020 Sep; 10(3):e27. PubMed ID: 30409775
[TBL] [Abstract][Full Text] [Related]
23. Palliative care integration and end-of-life care intensity for patients with NSCLC.
Martin A; Carton M; Thery L; Burnod A; Daniel C; Du Rusquec P; Girard N; Bouleuc C
Lung Cancer; 2024 Jun; 192():107800. PubMed ID: 38728972
[TBL] [Abstract][Full Text] [Related]
24. Do multidisciplinary team meetings make a difference in the management of lung cancer?
Boxer MM; Vinod SK; Shafiq J; Duggan KJ
Cancer; 2011 Nov; 117(22):5112-20. PubMed ID: 21523766
[TBL] [Abstract][Full Text] [Related]
25. Timeliness of Treatment Initiation and Associated Survival Following Diagnosis of Non-Small-Cell Lung Cancer in South Carolina.
Bullard JT; Eberth JM; Arrington AK; Adams SA; Cheng X; Salloum RG
South Med J; 2017 Feb; 110(2):107-113. PubMed ID: 28158880
[TBL] [Abstract][Full Text] [Related]
26. Components of early outpatient palliative care consultation in patients with metastatic nonsmall cell lung cancer.
Jacobsen J; Jackson V; Dahlin C; Greer J; Perez-Cruz P; Billings JA; Pirl W; Temel J
J Palliat Med; 2011 Apr; 14(4):459-64. PubMed ID: 21417739
[TBL] [Abstract][Full Text] [Related]
27. Age and treatment of non-small-cell lung cancer: a database analysis in elderly patients.
Berghmans T; Tragas G; Sculier JP
Support Care Cancer; 2002 Nov; 10(8):619-23. PubMed ID: 12436220
[TBL] [Abstract][Full Text] [Related]
28. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
[TBL] [Abstract][Full Text] [Related]
29. Early palliative intervention for patients with advanced cancer.
Otsuka M; Koyama A; Matsuoka H; Niki M; Makimura C; Sakamoto R; Sakai K; Fukuoka M
Jpn J Clin Oncol; 2013 Aug; 43(8):788-94. PubMed ID: 23737605
[TBL] [Abstract][Full Text] [Related]
30. Radiotherapy patterns of care for stage I and II non-small cell lung cancer in Sydney, Australia.
Nguyen AD; Wong W; Beydoun N; Mohan S; Shafiq J; Vinod SK
J Med Imaging Radiat Oncol; 2019 Feb; 63(1):131-141. PubMed ID: 30281917
[TBL] [Abstract][Full Text] [Related]
31. Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.
Kuiper JL; Hendriks LE; van der Wekken AJ; de Langen AJ; Bahce I; Thunnissen E; Heideman DA; Berk Y; Buijs EJ; Speel EJ; Krouwels FH; Smit HJ; Groen HJ; Dingemans AM; Smit EF
Lung Cancer; 2015 Sep; 89(3):255-61. PubMed ID: 26117231
[TBL] [Abstract][Full Text] [Related]
32. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
[TBL] [Abstract][Full Text] [Related]
33. Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib.
Yao ZH; Liao WY; Ho CC; Chen KY; Shih JY; Chen JS; Lin ZZ; Lin CC; Chih-Hsin Yang J; Yu CJ
Oncologist; 2017 Sep; 22(9):1075-1083. PubMed ID: 28507206
[TBL] [Abstract][Full Text] [Related]
34. Metastatic non-small cell lung cancer: a benchmark for quality end-of-life cancer care?
Philip J; Hudson P; Bostanci A; Street A; Horey DE; Aranda S; Zordan R; Rumbold BD; Moore G; Sundararajan V
Med J Aust; 2015 Feb; 202(3):139-43. PubMed ID: 25669476
[TBL] [Abstract][Full Text] [Related]
35. Cancer Patients Dying in the Intensive Care Units and Access to Palliative Care.
Ledoux M; Tricou C; Roux M; Dreano-Hartz S; Ruer M; Filbet M
J Palliat Med; 2018 May; 21(5):689-693. PubMed ID: 29480751
[TBL] [Abstract][Full Text] [Related]
36. A Population-based Study of Treatment Patterns and Survival of Patients With De Novo Stage IV Non-Small Cell Lung Cancer.
Batra A; Yusuf D; Hurry M; Walton RN; Devost N; Farrer C; Cheung WY
Am J Clin Oncol; 2021 Oct; 44(10):512-518. PubMed ID: 34380947
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care.
Temel JS; Greer JA; Admane S; Gallagher ER; Jackson VA; Lynch TJ; Lennes IT; Dahlin CM; Pirl WF
J Clin Oncol; 2011 Jun; 29(17):2319-26. PubMed ID: 21555700
[TBL] [Abstract][Full Text] [Related]
38. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
Koch A; Fohlin H; Sörenson S
J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
[TBL] [Abstract][Full Text] [Related]
40. Stage III non-small-cell lung cancer: Establishing a benchmark for the proportion of patients suitable for radical treatment.
Al-Shamsi HO; Al Farsi A; Ellis PM
Clin Lung Cancer; 2014 Jul; 15(4):274-80. PubMed ID: 24685356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
